DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 11DR REDDYS
02 6DR REDDYS LABS INC
03 12STRIDES PHARMA
04 3ACCORD HLTHCARE
05 4ACCORD HLTHCARE INC
06 3ADHERA
07 4AJANTA PHARMA LTD
08 23ALEMBIC
09 3ALKEM
10 4ALKEM LABS LTD
11 4AMNEAL
12 3AMNEAL PHARMS NY
13 11APDM PHARMS
14 8APOTEX
15 16AUROBINDO PHARMA
16 6AUROBINDO PHARMA LTD
17 4BOEHRINGER INGELHEIM
18 12CHARTWELL RX
19 3CHINA RESOURCES
20 3CIPLA
21 1CMP DEV LLC
22 3COREPHARMA
23 9COSETTE
24 5ENDO OPERATIONS
25 3EPIC PHARMA LLC
26 3GEDEON RICHTER USA
27 3GENPHARM
28 4GLENMARK PHARMS LTD
29 2GRAVITI PHARMS
30 6HERITAGE
31 4HETERO LABS
32 4HETERO LABS LTD V
33 3HIKMA
34 3HIKMA PHARMS
35 6INVAGEN PHARMS
36 4JUBILANT GENERICS
37 7LUPIN
38 9LUPIN LTD
39 7LUPIN PHARMS
40 18MACLEODS PHARMS LTD
41 4MATRIX LABS LTD
42 4MICRO LABS
43 22MYLAN
44 6NORVIUM BIOSCIENCE
45 18NOVARTIS
46 4NOVEL LABS INC
47 3ORBION PHARMS
48 3OXFORD PHARMS
49 11PHARMACIA
50 3PHARMOBEDIENT
51 5PIRAMAL
52 3POLYGEN PHARMS
53 3PURACAP PHARM
54 3PURPLE BIOTECH
55 6SANDOZ
56 7SCIEGEN PHARMS INC
57 3SOVEREIGN PHARMS
58 3SUN PHARM INDS INC
59 3SUN PHARM INDS LTD
60 3SUN PHARM INDUSTRIES
61 3SUNSHINE
62 6SYNTHON PHARMS
63 3TEVA
64 11TEVA PHARMS
65 13TEVA PHARMS USA
66 22TORRENT
67 3TORRENT PHARMS
68 3UNICHEM
69 3VIATRIS
70 7WATSON LABS
71 2WATSON LABS INC
72 3WOCKHARDT
73 4ZYDUS PHARMS
74 3ZYDUS PHARMS USA
75 4ZYDUS PHARMS USA INC
01 5CAPSULE; ORAL
02 58CAPSULE;ORAL
03 1SOLUTION;ORAL
04 3TABLET, ORALLY DISINTEGRATING;ORAL
05 4TABLET; ORAL
06 383TABLET;ORAL
01 155DISCN
02 285RX
03 14Blank
01 60AMLODIPINE AND OLMESARTAN MEDOXOMIL
02 116AMLODIPINE BESYLATE
03 52AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
04 52AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
05 40AMLODIPINE BESYLATE AND VALSARTAN
06 30AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
07 5AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
08 5AMTURNIDE
09 4AZOR
10 11CADUET
11 3CONSENSI
12 4EXFORGE
13 5EXFORGE HCT
14 6LOTREL
15 1NORLIQVA
16 3NORVASC
17 25OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
18 3PRESTALIA
19 4TEKAMLO
20 16TELMISARTAN AND AMLODIPINE
21 5TRIBENZOR
22 4TWYNSTA
01 388No
02 52Yes
03 14Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Brand Name : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 2.5MG BASE;10MG
Approval Date : 2010-04-15
Application Number : 77183
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code : AB
Brand Name : AMLODIPINE BESYLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2007-07-11
Application Number : 77516
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Brand Name : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 5MG BASE;10MG
Approval Date : 2010-04-15
Application Number : 77183
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Brand Name : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 5MG BASE;20MG
Approval Date : 2010-04-15
Application Number : 77183
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Brand Name : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 10MG BASE;20MG
Approval Date : 2010-04-15
Application Number : 77183
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Brand Name : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 5MG BASE;40MG
Approval Date : 2011-07-05
Application Number : 90149
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Brand Name : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 10MG BASE;40MG
Approval Date : 2011-07-05
Application Number : 90149
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
Brand Name : AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 2.5MG BASE;EQ 10MG BASE
Approval Date : 2014-03-07
Application Number : 203874
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
Brand Name : AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 2.5MG BASE;EQ 20MG BASE
Approval Date : 2014-03-07
Application Number : 203874
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
Brand Name : AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 2.5MG BASE;EQ 40MG BASE
Approval Date : 2014-03-07
Application Number : 203874
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
